Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG solutions for colonoscopy preparation in children
2008-003244-11Phase 3Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of macrogol 4000 (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoints: Efficacy of intestinal cleansing, Tolerability and adverse events and 2 more. Started Mar 2009; status: completed.
02
Drugs
macrogol 4000
Beyond the preview
Go deeper on 2008-003244-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003244-11.